Indeed, the combination of FBL mRNA level and tumor size highlighted three categories of breast cancer patients: patients with the best OS and DFS that carry small tumors expressing intermediate FBL mRNA levels; patients with the poorest OS and DFS that carry large tumors expressing low FBL mRNA levels; and patients with intermediate survival exhibiting other combinations. This evidence concerns the gene FBL and breast cancer.